National Comprehensive Cancer Network



About NCCN

Acute Lymphoblastic Leukemia Panel - Disclosures as of 2/28/2014

View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures

Panel Member Clinical Research Support/Data Safety Monitoring Board Advisory Boards, Speakers Bureau, Expert Witness, or Consultant Patent, Equity, or Royalty Other Date Completed

Joseph C. Alvarnas, MD

Clinical Trials Network

None

None

None

1/9/2013

Patricia Aoun, MD, MPH

None

None

None

None

8/26/2014

Karen Kuhn Ballen, MD

None

None

None

None

10/16/2014

Stefan K. Barta, MD, MS, MRCP

Millennium Pharmaceuticals, Inc.;
Kyowa Hakko Kirin;
Optimer;
Otsuka Pharmaceuticals;
Seattle Genetics

Celgene Corporation;
Onyx Pharmaceuticals, Inc.;
Seattle Genetics;
Pharmacyclics

None

None

9/24/2014

Naresh Bellam, MD, MPH

None

Celgene Corporation

None

None

7/16/2013

William Blum, MD

Celgene Corporation

Abbott Laboratories;
Genentech, Inc.;
Jannsen Pharmaceutica Products, LP

None

None

1/7/2014

Michael W. Boyer, MD

None

None

None

None

10/20/2013

Patrick A. Brown, MD

None

None

None

None

2/7/2013

Januario E. Castro, MD

       

Pending

Peter F. Coccia, MD

None

None

None

None

9/17/2014

Steven E. Coutre, MD

None

Celgene Corporation

None

None

9/16/2014

Lloyd E. Damon, MD

None

None

None

None

5/10/2014

Daniel J. DeAngelo, MD, PhD

None

ARIAD Pharmaceuticals, Inc.;
Bristol-Myers Squibb Company;
Novartis Pharmaceuticals Corporation;
Sigma-Tau Pharmaceuticals, Inc.

None

None

9/5/2013

Dan Douer, MD

Amgen Inc.;
Bristol-Myers Squibb Company;
Sigma-Tau Pharmaceuticals, Inc.

Amgen Inc.;
Enzon Pharmaceuticals;
Jazz Pharmaceuticals;
Spectrum;
Pfizer Inc.

None

None

10/13/2013

Haydar Frangoul, MD

None

None

None

None

5/4/2014

Olga Frankfurt, MD

None

None

None

None

10/14/2013

Lauren Gallagher, RPh, PhD

None

None

None

None

6/4/2014

Kristina M. Gregory, RN, MSN, OCN

None

None

None

None

9/16/2014

Robert A. Johnson, MD, FACP

None

None

None

None

10/14/2014

Arthur Liu, MD

None

None

None

None

10/16/2014

Joan S. McClure, MS

None

None

None

None

6/20/2014

Susan O'Brien, MD

Ariad;
Infinity;
Morphosys

Teva

None

None

8/27/2013

Arati V. Rao, MD

None

Spectrum

None

None

11/15/2013

Bijal Shah, MD

Celgene Corporation;
Seattle Genetics;
Spectrum Pharmaceuticals;
Pfizer Inc.

Celgene Corporation;
Jannsen Pharmaceutica Products, LP;
Spectrum Pharmaceuticals

None

None

1/22/2014

Andrei R. Shustov, MD

Talon Therapeutics;
Pfizer Inc.

Celgene Corporation

None

None

11/14/2013

Courtney Smith, PhD

None

None

None

None

3/4/2014

Sarika Trikha, PharmD

None

None

None

None

5/19/2014

Geoffrey Uy, MD

Novartis Pharmaceuticals Corporation;
Onyx Pharmaceuticals, Inc.;
sanofi-aventis U.S.

None

None

None

10/29/2013

Meir Wetzler, MD

Bristol-Myers Squibb Company

Teva

None

None

7/30/2014

Andrew D. Zelenetz, MD, PhD

None

Celgene Corporation;
Genentech, Inc.;
GlaxoSmithKline;
Onyx Pharmaceuticals, Inc.;
Bullet Bio Technology;
Cancer Genetics;
Dr. Reddy`s Laboratories;
Emergent Biosolutions;
Foundation Medicine;
Gilead;
Hospira;
Roche Laboratories, Inc.;
sanofi-aventis U.S.

None

None

6/16/2014